Therefore, investigating the relationship between T. gondii effectors and TBK1 would be beneficial in explaining why IFN‐I production is often limited compared to IFN‐γ during toxoplasmosis, and for further modification of T. gondii for IFN‐I‐based anti‐tumor therapy.[9]. Here, TBK1 is linked to neoplasm.